Statistical methods in psychiatry & mental health trials
The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.
ANCOVA
Mixed-effects model
MMRM (mixed model for repeated measures)
Multiple imputation / missing data
Cochran-Mantel-Haenszel test
Odds ratio
t-test
Logistic regression
All psychiatry & mental health trials
833 results
- Just Kwit: Mobile Intervention for Tobacco Cessation: Complete Statistical AnalysisIndependent statistical analysis of Just Kwit: Mobile Intervention for Tobacco Cessation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03538678).
- Kappa Opioid Receptor Antagonism for the Tx of AUD and Comorbid PTSD: Complete Statistical AnalysisIndependent statistical analysis of Kappa Opioid Receptor Antagonism for the Tx of AUD and Comorbid PTSD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- KAREIndependent statistical analysis of Ketamine for Reduction of Alcoholic Relapse: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02649231).
- KET-ROIndependent statistical analysis of KET-RO Plus RO DBT for Treatment Resistant Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06138691).
- Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder: Complete Statistical AnalysisIndependent statistical analysis of Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Ketamine in Borderline Personality Disorder: Complete Statistical AnalysisIndependent statistical analysis of Ketamine in Borderline Personality Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03395314).
- Ketamine Tolerated Dose for Postpartum Depression and Pain After Cesarean Delivery (PREPARE 1): Complete Statistical AnalysisIndependent statistical analysis of Ketamine Tolerated Dose for Postpartum Depression and Pain After Cesarean Delivery (PREPARE 1): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Ketogenic Diet (KD) in Alcoholism: Complete Statistical AnalysisIndependent statistical analysis of Ketogenic Diet (KD) in Alcoholism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03255031).
- KetPTSDIndependent statistical analysis of Ketamine as a Rapid Treatment for Post-traumatic Stress Disorder (PTSD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00749203).
- KINETICIndependent statistical analysis of Ketamine to Improve Recovery After Cesarean Delivery - Part 1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04037085).
- KIS-IVIndependent statistical analysis of Advancing Tobacco Use Treatment for African American Smokers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02360631).
- L-arginine in Treatment as Usual in Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of L-arginine in Treatment as Usual in Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00718510).
- Laboratory Study of Cannabidiol on the Effects of Smoked Marijuana: Complete Statistical AnalysisIndependent statistical analysis of Laboratory Study of Cannabidiol on the Effects of Smoked Marijuana: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01844687).
- Large-scale Brain Organization During Cognitive Control in ADHD: Complete Statistical AnalysisIndependent statistical analysis of Large-scale Brain Organization During Cognitive Control in ADHD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04349917).
- Latino-SMARTIndependent statistical analysis of An Adaptive Intervention for Depression Among Latinos Living With HIV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03668379).
- Levetiracetam for the Treatment of Alcohol Dependence and Anxiety: Complete Statistical AnalysisIndependent statistical analysis of Levetiracetam for the Treatment of Alcohol Dependence and Anxiety: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00141115).
- Levetiracetam in the Management of Bipolar Depression: Complete Statistical AnalysisIndependent statistical analysis of Levetiracetam in the Management of Bipolar Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00566150).
- LFMSIndependent statistical analysis of LFMS: Initial Trial in Geriatric Bipolar Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02707276).
- Lifestyle Intervention in Preparation for Pregnancy (LIPP): Complete Statistical AnalysisIndependent statistical analysis of Lifestyle Intervention in Preparation for Pregnancy (LIPP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03146156).
- LINK: Aftercare Monitoring Project: Complete Statistical AnalysisIndependent statistical analysis of LINK: Aftercare Monitoring Project: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00265512).
- Little Cigar and Cigarillo Warnings for Youth: Complete Statistical AnalysisIndependent statistical analysis of Little Cigar and Cigarillo Warnings for Youth: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06413797).
- Long-term Efficacy, Safety and Tolerability of Pramipexole in Patients With Idiopathic Moderate to Severe Restless Legs Syndrome (RLS): Complete Statistical AnalysisIndependent statistical analysis of Long-term Efficacy, Safety and Tolerability of Pramipexole in Patients With Idiopathic Moderate to Severe Restless Legs Syndrome (RLS): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Long-term Extension Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Long-term Extension Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Long-term Study of Asenapine in Participants With Residual Subtype, Receiving Multiple or/and High Dose Drugs, or Treatment Refractory Schizophrenia (P06238): Complete Statistical AnalysisIndependent statistical analysis of Long-term Study of Asenapine in Participants With Residual Subtype, Receiving Multiple or/and High Dose Drugs, or Treatment Refractory Schizophrenia (P06238): primary endpoint results, effect estimate with confidence interval,…
- Long-Term Study of Gabapentin Enacarbil (GEn, XP13512) vs. Placebo in Patients With Restless Legs Syndrome.: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Study of Gabapentin Enacarbil (GEn, XP13512) vs. Placebo in Patients With Restless Legs Syndrome.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Low Nicotine Cigarettes Plus Electronic Cigarettes: Complete Statistical AnalysisIndependent statistical analysis of Low Nicotine Cigarettes Plus Electronic Cigarettes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04058717).
- Low-Dose Naltrexone (LDN) for Depression Relapse and Recurrence: Complete Statistical AnalysisIndependent statistical analysis of Low-Dose Naltrexone (LDN) for Depression Relapse and Recurrence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01874951).
- MAGELLANIndependent statistical analysis of Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Magnetic Resonance Imaging Study of Lisdexamfetamine for Bipolar Depression: Complete Statistical AnalysisIndependent statistical analysis of Magnetic Resonance Imaging Study of Lisdexamfetamine for Bipolar Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01051440).
- Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive Glioblastoma: Complete Statistical AnalysisIndependent statistical analysis of Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive Glioblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00551161).
- MAINIndependent statistical analysis of Memory and Insulin in Early Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00581867).
- Maintaining Nonsmoking: Older Smokers – 1: Complete Statistical AnalysisIndependent statistical analysis of Maintaining Nonsmoking: Older Smokers - 1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00086385).
- Making Better Lives: Patient-Focused Care for Low Back Pain (LBP): Complete Statistical AnalysisIndependent statistical analysis of Making Better Lives: Patient-Focused Care for Low Back Pain (LBP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02697435).
- Management of Chronic Pain and PTSD in Gulf War Veterans With tDCS+Prolonged Exposure: Complete Statistical AnalysisIndependent statistical analysis of Management of Chronic Pain and PTSD in Gulf War Veterans With tDCS+Prolonged Exposure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MAP4BUPIndependent statistical analysis of Mobile Medication Adherence Platform for Buprenorphine-Naloxone During Treatment of Opioid Use Disorder: Phase I Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- MARSIndependent statistical analysis of Project MARS: Mobile-Assistance for Regulating Smoking: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04376489).
- MBCT Delivered Via Group Videoconferencing for ACS Patients With Elevated Depression Symptoms: Complete Statistical AnalysisIndependent statistical analysis of MBCT Delivered Via Group Videoconferencing for ACS Patients With Elevated Depression Symptoms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- MBIIndependent statistical analysis of Mechanisms of Mindfulness-based Interventions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03571386).
- MBSRIndependent statistical analysis of Mindfulness-Based Stress Reduction for Adults With Low-Risk Chest Pain Associated With Anxiety: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- MDMNIndependent statistical analysis of Modulating Default Mode Network Function: A Transcranial Direct Current Stimulation (TDCS) Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Mechanisms of Antidepressant Non-Response in Late-Life Depression: Complete Statistical AnalysisIndependent statistical analysis of Mechanisms of Antidepressant Non-Response in Late-Life Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01931202).
- MEDEXIndependent statistical analysis of A Multi-level Life-span Characterization of Adult-depression and Effects of Medication and Exercise: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Medication Treatment for Depression in Nursing Home Residents: Complete Statistical AnalysisIndependent statistical analysis of Medication Treatment for Depression in Nursing Home Residents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00076622).
- Medications for Stopping Cocaine Dependence and Preventing Relapse: Complete Statistical AnalysisIndependent statistical analysis of Medications for Stopping Cocaine Dependence and Preventing Relapse: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00218023).
- Melatonin for Circadian Sleep Disorders in the Blind: Complete Statistical AnalysisIndependent statistical analysis of Melatonin for Circadian Sleep Disorders in the Blind: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00911053).
- Melatonin Intervention For Neurocognitive Deficits in the St. Jude Lifetime Cohort: Complete Statistical AnalysisIndependent statistical analysis of Melatonin Intervention For Neurocognitive Deficits in the St. Jude Lifetime Cohort: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Memantine Augmentation of Lamotrigine Incomplete-Response in Bipolar Depression: Complete Statistical AnalysisIndependent statistical analysis of Memantine Augmentation of Lamotrigine Incomplete-Response in Bipolar Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00305578).
- Memantine Effects on Sensorimotor Gating and Neurocognition in Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Memantine Effects on Sensorimotor Gating and Neurocognition in Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03860597).
- Menopausal Sleep Fragmentation and Body Fat Gain: Complete Statistical AnalysisIndependent statistical analysis of Menopausal Sleep Fragmentation and Body Fat Gain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03047330).